Home » Authors » Mark McCarty

Articles by Mark McCarty

SEC's Treadway group issues new small-cap SOX guidance

July 13, 2006

By Mark McCarty

Panel: U.S. universal coverage will come with less med-tech

July 13, 2006

By Mark McCarty

Moratorium on Medicare cuts for imaging eyed in H.R. 5704

July 13, 2006

By Mark McCarty

FDA to roll out 'track-and-trace' for drugs; devices may follow

July 12, 2006

By Mark McCarty

Internet seen as conduit for best-practices dissemination

July 11, 2006

By Mark McCarty

Panel: U.S. universal coverage will come with less med-tech

July 10, 2006

By Mark McCarty

HSAs: fairly traditional coverage – or 'extra dollars for the rich'?

July 6, 2006

By Mark McCarty

Moratorium on Medicare cuts for imaging eyed in H.R. 5704

July 6, 2006

By Mark McCarty

New FDA guidances aimed at reducing 'gridlock' of trials

July 5, 2006

By Mark McCarty

Risk analysis role in ICD implantation decision is debated

July 1, 2006

By Mark McCarty

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...